106 related articles for article (PubMed ID: 6450259)
1. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.
Lambris JD; Dobson NJ; Ross GD
J Exp Med; 1980 Dec; 152(6):1625-44. PubMed ID: 6450259
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the Alternative Pathway of Complement by Murine Factor H-Related Proteins.
Antonioli AH; White J; Crawford F; Renner B; Marchbank KJ; Hannan JP; Thurman JM; Marrack P; Holers VM
J Immunol; 2018 Jan; 200(1):316-326. PubMed ID: 29187587
[TBL] [Abstract][Full Text] [Related]
3. The human factor H protein family - an update.
Sándor N; Schneider AE; Matola AT; Barbai VH; Bencze D; Hammad HH; Papp A; Kövesdi D; Uzonyi B; Józsi M
Front Immunol; 2024; 15():1135490. PubMed ID: 38410512
[TBL] [Abstract][Full Text] [Related]
4. Complement factor H: a novel innate immune checkpoint in cancer immunotherapy.
Saxena R; Gottlin EB; Campa MJ; Bushey RT; Guo J; Patz EF; He YW
Front Cell Dev Biol; 2024; 12():1302490. PubMed ID: 38389705
[TBL] [Abstract][Full Text] [Related]
5. A guide to complement biology, pathology and therapeutic opportunity.
Mastellos DC; Hajishengallis G; Lambris JD
Nat Rev Immunol; 2024 Feb; 24(2):118-141. PubMed ID: 37670180
[TBL] [Abstract][Full Text] [Related]
6. Regulation of anti-microbial autophagy by factors of the complement system.
Viret C; Rozières A; Duclaux-Loras R; Boschetti G; Nancey S; Faure M
Microb Cell; 2020 Mar; 7(4):93-105. PubMed ID: 32274388
[TBL] [Abstract][Full Text] [Related]
7. New insights into the immune functions of complement.
Reis ES; Mastellos DC; Hajishengallis G; Lambris JD
Nat Rev Immunol; 2019 Aug; 19(8):503-516. PubMed ID: 31048789
[TBL] [Abstract][Full Text] [Related]
8. Self-Damage Caused by Dysregulation of the Complement Alternative Pathway: Relevance of the Factor H Protein Family.
Sánchez-Corral P; Pouw RB; López-Trascasa M; Józsi M
Front Immunol; 2018; 9():1607. PubMed ID: 30050540
[TBL] [Abstract][Full Text] [Related]
9. The renaissance of complement therapeutics.
Ricklin D; Mastellos DC; Reis ES; Lambris JD
Nat Rev Nephrol; 2018 Jan; 14(1):26-47. PubMed ID: 29199277
[TBL] [Abstract][Full Text] [Related]
10. Novel mechanisms and functions of complement.
Hajishengallis G; Reis ES; Mastellos DC; Ricklin D; Lambris JD
Nat Immunol; 2017 Nov; 18(12):1288-1298. PubMed ID: 29144501
[TBL] [Abstract][Full Text] [Related]
11. Complement factor H in host defense and immune evasion.
Parente R; Clark SJ; Inforzato A; Day AJ
Cell Mol Life Sci; 2017 May; 74(9):1605-1624. PubMed ID: 27942748
[TBL] [Abstract][Full Text] [Related]
12. Molecular insights into the surface-specific arrangement of complement C5 convertase enzymes.
Berends ET; Gorham RD; Ruyken M; Soppe JA; Orhan H; Aerts PC; de Haas CJ; Gros P; Rooijakkers SH
BMC Biol; 2015 Nov; 13():93. PubMed ID: 26552476
[TBL] [Abstract][Full Text] [Related]
13. Factor h: a complement regulator in health and disease, and a mediator of cellular interactions.
Kopp A; Hebecker M; Svobodová E; Józsi M
Biomolecules; 2012 Feb; 2(1):46-75. PubMed ID: 24970127
[TBL] [Abstract][Full Text] [Related]
14. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.
Wu J; Wu YQ; Ricklin D; Janssen BJ; Lambris JD; Gros P
Nat Immunol; 2009 Jul; 10(7):728-33. PubMed ID: 19503104
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
Rooijakkers SH; Wu J; Ruyken M; van Domselaar R; Planken KL; Tzekou A; Ricklin D; Lambris JD; Janssen BJ; van Strijp JA; Gros P
Nat Immunol; 2009 Jul; 10(7):721-7. PubMed ID: 19503103
[TBL] [Abstract][Full Text] [Related]
16. Effects of two types of cobra venom factor on porcine complement activation and pulmonary artery pressure.
Cheung AK; Parker CJ; Wilcox L
Clin Exp Immunol; 1989 Nov; 78(2):299-306. PubMed ID: 12412765
[TBL] [Abstract][Full Text] [Related]
17. Rat complement factor I: molecular cloning, sequencing and expression in tissues and isolated cells.
Schlaf G; Rothermel E; Oppermann M; Schieferdecker HL; Jungermann K; Götze O
Immunology; 1999 Nov; 98(3):464-74. PubMed ID: 10583609
[TBL] [Abstract][Full Text] [Related]
18. Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules.
Vĕtvicka V; Hanikýrová M; Vĕtvicková J; Ross GD
Clin Exp Immunol; 1999 Feb; 115(2):229-35. PubMed ID: 9933447
[TBL] [Abstract][Full Text] [Related]
19. Solubilization of an activity regulating C3b function from Raji cell membranes.
Carlson P; Ruddy S; Conrad DH
Immunology; 1982 May; 46(1):163-73. PubMed ID: 7042548
[TBL] [Abstract][Full Text] [Related]
20. Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.
Parker CJ; Baker PJ; Rosse WF
J Clin Invest; 1982 Feb; 69(2):337-46. PubMed ID: 6915939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
